Found 6 Mood Disorders trials
A listing of Mood Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
COMP 006
In this study, the aim is to assess the efficacy after one and two administrations of COMP360 25 mg or COMP360 10 mg versus COMP360 1 mg for reducing symptom severity in TRD, when administered with psychological support.
Disentangling the Role of Depression in Hypersomnia
The goal of this study is to further our understanding of the relationship between depression and hypersomnia by examining mood-relevant domains of slow wave sleep and reward function.
ITI-007-505
This is an international, multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in patients with a primary diagnosis of MDD to evaluate the efficacy of lumateperone 42 mg administered once daily compared with placebo as adjunctive treatment to antidepressant therapy
REL-1017-304
A randomized, double-blind, placebo-controlled Phase 3 trial of REL-1017 in Major Depressive Disorder (MDD) as an adjunctive therapy
67953964MDD3001 VENTURA-1
Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
SOL-MDD-301
The purpose of this research study is to determine whether the study drug, Solriamfetol, is safe and effective for the treatment of Major Depressive Disorder (MDD). Solriamfetol, also called Sunosi®, is approved by the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) for people who …
